LONG-TERM TOXICITY OF BEVACIZUMAB IN PATIENTS WITH NEUROFIBROMATOSIS 2

被引：0
|
作者：
Merker, Vanessa [1 ]
Slusarz, Katie [1 ]
Muzikansky, Alona [1 ]
Francis, Sanjeev [1 ]
Plotkin, Scott [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：121 / 121
页数：1
相关论文
共 50 条
  • [1] Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients
    Katherine M. Slusarz
    Vanessa L. Merker
    Alona Muzikansky
    Sanjeev A. Francis
    Scott R. Plotkin
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 73 : 1197 - 1204
  • [2] Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients
    Slusarz, Katherine M.
    Merker, Vanessa L.
    Muzikansky, Alona
    Francis, Sanjeev A.
    Plotkin, Scott R.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) : 1197 - 1204
  • [3] Long-Term Effects of Bevacizumab on Vestibular Schwannoma Volume in Neurofibromatosis Type 2 Patients
    Killeen, Daniel E.
    Klesse, Laura
    Tolisano, Anthony M.
    Hunter, Jacob B.
    Kutz, Joe Walter, Jr.
    [J]. JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2019, 80 (05) : 540 - 545
  • [4] Long-term bevacizumab toxicity in patients with recurrent ovarian cancer
    Greenwade, M.
    Martin, J. Y.
    Hendrix, E.
    Ding, K.
    Dvorak, J.
    Moore, K. N.
    Goff, B. A.
    Holman, L. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 95 - 96
  • [5] Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2
    Bosch, Martina M.
    Boltshauser, Eugen
    Harpes, Paul
    Landau, Klara
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 141 (06) : 1068 - 1077
  • [6] Long-term visual outcomes in patients with orbitotemporal neurofibromatosis
    Greenwell, Timothy H.
    Anderson, Peter J.
    Madge, Simon K.
    Selva, Dinesh
    David, David J.
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 (03): : 266 - 270
  • [7] Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2
    Otsuka, G
    Saito, K
    Nagatani, T
    Yoshida, J
    [J]. JOURNAL OF NEUROSURGERY, 2003, 99 (03) : 480 - 483
  • [8] A Long-Term Extension Study of Bevacizumab in Patients With Solid Tumors
    Oza, Amit M.
    Dubois, Francois
    Hegg, Roberto
    Hernandez, Carlos Alberto
    Finocchiaro, Gaetano
    Ghiringhelli, Francois
    Zamagni, Claudio
    Nick, Sonja
    Irahara, Natsumi
    Perretti, Thomas
    Colombo, Nicoletta
    [J]. ONCOLOGIST, 2021, 26 (12): : E2254 - E2264
  • [9] Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort
    Morris, Katrina A.
    Golding, John F.
    Blesing, Claire
    Evans, D. Gareth
    Ferner, Rosalie E.
    Foweraker, Karen
    Halliday, Dorothy
    Jena, Raj
    McBain, Catherine
    McCabe, Martin G.
    Swampillai, Angela
    Warner, Nicola
    Wilson, Shaun
    Parry, Allyson
    Afridi, Shazia K.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (01) : 117 - 124
  • [10] Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort
    Katrina A. Morris
    John F. Golding
    Claire Blesing
    D. Gareth Evans
    Rosalie E. Ferner
    Karen Foweraker
    Dorothy Halliday
    Raj Jena
    Catherine McBain
    Martin G. McCabe
    Angela Swampillai
    Nicola Warner
    Shaun Wilson
    Allyson Parry
    Shazia K. Afridi
    [J]. Journal of Neuro-Oncology, 2017, 131 : 117 - 124
12345